1887

Chapter 28 : Polyomaviruses

MyBook is a cheap paperback edition of the original book and will be sold at uniform, low price.

Ebook: Choose a downloadable PDF or ePub file. Chapter is a downloadable PDF file. File must be downloaded within 48 hours of purchase

Buy this Chapter
Digital (?) $30.00

Preview this chapter:
Zoom in
Zoomout

Polyomaviruses, Page 1 of 2

| /docserver/preview/fulltext/10.1128/9781555819439/9781555819422.ch28-1.gif /docserver/preview/fulltext/10.1128/9781555819439/9781555819422.ch28-2.gif

Abstract:

Polyomavirus infections are widespread among humans and animals. The prototype of this viral family, polyoma virus of mice, was discovered in 1953 as an agent capable of producing tumors in its natural host (1). A second polyomavirus, murine K virus (KV; now known as mouse pneumotropic virus or MPtV), was discovered in 1952 (2). The simian polyomavirus, SV40, was discovered in 1960 as a contaminant of lots of rhesus monkey kidney cells used to prepare polio vaccine stocks (3). Infectious SV40, subsequently detected in both the Salk and Sabin polio vaccines, as well as in adenovirus vaccines, was inadvertently administered to millions of individuals worldwide (3).

Citation: Greenlee J, Hirsch H. 2017. Polyomaviruses, p 599-623. In Richman D, Whitley R, Hayden F (ed), Clinical Virology, Fourth Edition. ASM Press, Washington, DC. doi: 10.1128/9781555819439.ch28
Highlighted Text: Show | Hide
Loading full text...

Full text loading...

Figures

Image of FIGURE 1
FIGURE 1

Electron micrograph of BKPyV extracted from human fetal kidney cells, concentrated by ultracentrifugation, and stained with 2% phosphotungstic acid, showing characteristic 42 nm particles.

Citation: Greenlee J, Hirsch H. 2017. Polyomaviruses, p 599-623. In Richman D, Whitley R, Hayden F (ed), Clinical Virology, Fourth Edition. ASM Press, Washington, DC. doi: 10.1128/9781555819439.ch28
Permissions and Reprints Request Permissions
Download as Powerpoint
Image of FIGURE 2
FIGURE 2

Schematic representation of a human polyomavirus genome, made up of circular double-stranded DNA. Regions comprising the NCCR are shown in blue; those comprising the EVGR are shown in red: these encode LTag, truncT’ as found in MCPyV, and sTag. LVGR sequences encoding VP1, VP2, VP3, and the agno protein are shown in red. The agno protein-encoding gene is not found in every HPyV genome.

Citation: Greenlee J, Hirsch H. 2017. Polyomaviruses, p 599-623. In Richman D, Whitley R, Hayden F (ed), Clinical Virology, Fourth Edition. ASM Press, Washington, DC. doi: 10.1128/9781555819439.ch28
Permissions and Reprints Request Permissions
Download as Powerpoint
Image of FIGURE 3
FIGURE 3

(A) Identification of SV40 T-Ag by immunofluorescence in transformed simian TC-7 kidney cells. Cells were grown in a monolayer and reacted with monoclonal antibodies PAb 416, PAb 108, and PAb 101 directed against T-Ag as described by O'Neill et al. ( ). (B) Naïve TC-7 cells (not containing T-Ag-encoding DNA sequences) reacted with monoclonal antibodies as in panel A (negative control).

Citation: Greenlee J, Hirsch H. 2017. Polyomaviruses, p 599-623. In Richman D, Whitley R, Hayden F (ed), Clinical Virology, Fourth Edition. ASM Press, Washington, DC. doi: 10.1128/9781555819439.ch28
Permissions and Reprints Request Permissions
Download as Powerpoint
Image of FIGURE 4
FIGURE 4

Western blot of SV40 T-Ag and p53 from transformed human cells. SV40 T-Ag was immunoprecipitated in even-numbered lanes and p53 was immunoprecipitated in odd-numbered lanes, and the immunoprecipitates were subjected to electrophoresis in agarose gels and analyzed by Western blotting using a cocktail of antibodies to T-Ag or p53 ( ). The illustration shows that immunoprecipitation of either protein results in coprecipitation of the second protein.

Citation: Greenlee J, Hirsch H. 2017. Polyomaviruses, p 599-623. In Richman D, Whitley R, Hayden F (ed), Clinical Virology, Fourth Edition. ASM Press, Washington, DC. doi: 10.1128/9781555819439.ch28
Permissions and Reprints Request Permissions
Download as Powerpoint
Image of FIGURE 5
FIGURE 5

Comparative cytopathic effects produced by JCPyV, BKPyV, and SV40 in primary cultures of human fetal brain cells. Cultures were infected with a 1/10 dilution of the PML-associated Mad-1 genotype of JCPyV or with 1/1,000 dilutions of SV40 or BKPyV. (A) Uninfected human fetal brain cells containing relatively small, moderately stained nuclei. (B) Cultures infected with a 1/10 dilution of the PML-associated Mad-1 strain of JCPyV, showing cells with enlarged nuclei and multinucleated cells. Occasional giant multinucleated cells were present in some cultures (not shown). (C) Cultures infected with a 1/1,000 dilution of SV40. Cultures show large, darkly staining nuclei. Some nuclei were reticulated or mottled (double arrows), but multinucleated cells were rare. Arrowheads in panels B and C designate cells with small nuclei, similar to those seen in uninfected cultures. (D) Cultures infected with a 1/1,000 dilution of BKPyV, showing enlarged, intensely stained nuclei. Some nuclei contained what appeared to be doughnut-shaped nucleoli (arrows). This was unique to BKPyV infection. As in SV40-infected cultures, multinucleated cells were rarely present. In cultures infected with BKPyV or SV40, cytopathic effect became extensive within 8 to 10 days. In cells infected with Mad-1 JCPyV, cytopathic effect did not appear until 3 to 4 weeks. (Wright's stain; magnification, ×152).

Citation: Greenlee J, Hirsch H. 2017. Polyomaviruses, p 599-623. In Richman D, Whitley R, Hayden F (ed), Clinical Virology, Fourth Edition. ASM Press, Washington, DC. doi: 10.1128/9781555819439.ch28
Permissions and Reprints Request Permissions
Download as Powerpoint
Image of FIGURE 6
FIGURE 6

Polyomavirus persistence as a chronic productive infection, as shown in a kidney of a nonimmunosuppressed mouse 6 months after inoculation with murine pneumotropic (K) virus. Arrows indicate the presence of viral nucleic acids (A), T-Ag (B), and VP1 antigen (C) indicative of viral replication in renal tubular epithelial cells.

Citation: Greenlee J, Hirsch H. 2017. Polyomaviruses, p 599-623. In Richman D, Whitley R, Hayden F (ed), Clinical Virology, Fourth Edition. ASM Press, Washington, DC. doi: 10.1128/9781555819439.ch28
Permissions and Reprints Request Permissions
Download as Powerpoint
Image of FIGURE 7
FIGURE 7

Section from edge of a PML lesion, stained for polyomavirus common structural antigen, and labeled using immunoperoxidase techniques. There is extensive loss of myelin. Oligodendrocytes have enlarged nuclei that exhibit intense immunostaining indicating productive infection (arrows). Giant astrocytes within the lesion remain unlabeled. Magnification, ×216.

Citation: Greenlee J, Hirsch H. 2017. Polyomaviruses, p 599-623. In Richman D, Whitley R, Hayden F (ed), Clinical Virology, Fourth Edition. ASM Press, Washington, DC. doi: 10.1128/9781555819439.ch28
Permissions and Reprints Request Permissions
Download as Powerpoint
Image of FIGURE 8
FIGURE 8

Section of PML-affected brain probed for JCPyV nucleic acids using hybridization methods. Large numbers of exposed emulsion grains, indicative of specific hybridization, overlie nuclei of infected oligodendrocytes. Smaller numbers of exposed emulsion grains overlie atypical astrocytes, again indicating presence of viral nucleic acids. Magnification, ×400.

Citation: Greenlee J, Hirsch H. 2017. Polyomaviruses, p 599-623. In Richman D, Whitley R, Hayden F (ed), Clinical Virology, Fourth Edition. ASM Press, Washington, DC. doi: 10.1128/9781555819439.ch28
Permissions and Reprints Request Permissions
Download as Powerpoint
Image of FIGURE 9
FIGURE 9

Urine and allograft-biopsy specimens from a patient with BKPyV-associated nephropathy. (A) Urine cytology showing “decoy cells” with their characteristic ground-glass, intranuclear viral inclusion bodies (arrows) (Papanicolaou stain, ×400). (B) Allograft-biopsy showing renal tubules with epithelial cells containing viral inclusions, nuclear enlargement, and detachment of infected cells from the tubular basement membrane, leading to its denudation (arrows) (hematoxylin and eosin, ×160). Adapted from reference with the permission of the publisher.)

Citation: Greenlee J, Hirsch H. 2017. Polyomaviruses, p 599-623. In Richman D, Whitley R, Hayden F (ed), Clinical Virology, Fourth Edition. ASM Press, Washington, DC. doi: 10.1128/9781555819439.ch28
Permissions and Reprints Request Permissions
Download as Powerpoint
Image of FIGURE 10
FIGURE 10

Histological patterns of polyomavirus-associated nephropathy (PVAN) in kidney transplant biopsies. (A) BKPyV nephropathy pattern A consisting of focal viral cytopathic changes with little inflammation or tubular atrophy of a patient with a BKPyV archetype NCCR in plasma. Hematoxylin/eosin stain of a representative histological field and immunohistochemistry of LTag expression using the cross-reacting monoclonal anti-SV40 T-antigen Ab-2 and peroxidase-conjugated anti-mouse IgG. Enlargement of the indicated area is shown. (B) BKPyV nephropathy pattern A consisting of extensive viral cytopathic changes and inflammatory infiltrates of patient carrying BKPyV rearranged (rr-)NCCR variant in plasma. Hematoxylin/eosin stain of a representative histological field and immunohistochemistry of LTag expression using the cross-reacting monoclonal anti-SV40 T-antigen Ab-2 and peroxidase conjugated anti-mouse. Bars: (A and B) 200 μm; (A and B, insets) 100 μm. Reprinted from Gosert R, Rinaldo CH, Funk GA, Egli A, Ramos E, Drachenberg CB Hirsch HH. 2008. Polyomavirus BK with rearranged noncoding control region emerge in vivo in renal transplant patients and increase viral replication and cytopathology. 841–852 with the permission of the author and publisher.

Citation: Greenlee J, Hirsch H. 2017. Polyomaviruses, p 599-623. In Richman D, Whitley R, Hayden F (ed), Clinical Virology, Fourth Edition. ASM Press, Washington, DC. doi: 10.1128/9781555819439.ch28
Permissions and Reprints Request Permissions
Download as Powerpoint
Image of FIGURE 11
FIGURE 11

Fluid-attenuated inversion recovery (FLAIR) weighted magnetic resonance image of a patient developing PML in the setting of AIDS. Multifocal areas of demyelination are seen as areas of increased signal, appearing white against the darker background.

Citation: Greenlee J, Hirsch H. 2017. Polyomaviruses, p 599-623. In Richman D, Whitley R, Hayden F (ed), Clinical Virology, Fourth Edition. ASM Press, Washington, DC. doi: 10.1128/9781555819439.ch28
Permissions and Reprints Request Permissions
Download as Powerpoint

References

/content/book/10.1128/9781555819439.ch28
1. Gross L. 1953. A filterable agent, recovered from Ak leukemic extracts, causing salivary gland carcinomas in C3H mice. Proc Soc Exp Biol Med 83:414421.[PubMed]
2. Kilham L, Murphy HW. 1953. A pneumotropic virus isolated from C3H mice carrying the Bittner Milk Agent. Proc Soc Exp Biol Med 82:133137.[PubMed]
3. Shah KV. 2007. SV40 and human cancer: a review of recent data. Int J Cancer 120:215223.[PubMed]
4. Greenlee JE,. 1998. Progressive multifocal leukoencephalopathy, p 399430. In Aminoff MJ, Goetz CG (ed), Handbook of Clinical Neurology. Elsevier Science B.V., Amsterdam.
5. Padgett BL, Walker DL, ZuRhein GM, Eckroade RJ, Dessel BH. 1971. Cultivation of papova-like virus from human brain with progressive multifocal leucoencephalopathy. Lancet 1:12571260.[PubMed]
6. Gardner SD, Field AM, Coleman DV, Hulme B. 1971. New human papovavirus (B.K.) isolated from urine after renal transplantation. Lancet 1:12531257.[PubMed]
7. Arthur RR, Shah KV, Baust SJ, Santos GW, Saral R. 1986. Association of BK viruria with hemorrhagic cystitis in recipients of bone marrow transplants. N Engl J Med 315:230234.[PubMed]
8. Simon MA. 2008. Polyomaviruses of nonhuman primates: implications for research. Comp Med 58:5156.[PubMed]
9. Calvignac-Spencer S, Feltkamp MC, Daugherty MD, Moens U, Ramqvist T, Johne R, Ehlers B Polyomaviridae Study Group of the International Committee on Taxonomy of Viruses. 2016. A taxonomy update for the family Polyomaviridae. Arch Virol.[PubMed]
10. zur Hausen H. 2003. SV40 in human cancers—an endless tale? Int J Cancer 107:687.[PubMed]
11. DeCaprio JA, Imperiale MJ, Major EO,. 2013. Polyomaviruses, p 16331661. In Knipe DM, Howley PM (ed), Fields Virology, 6th ed. Wolters Kluwer, Philadelphia.
12. Van Ghelue M, Khan MT, Ehlers B, Moens U. 2012. Genome analysis of the new human polyomaviruses. Rev Med Virol 22:354377.[PubMed]
13. Yogo Y, Kitamura T, Sugimoto C, Ueki T, Aso Y, Hara K, Taguchi F. 1990. Isolation of a possible archetypal JC virus DNA sequence from nonimmunocompromised individuals. J Virol 64:31393143.[PubMed]
14. O'Neill FJ, Greenlee JE, Carney H. 2003. The archetype enhancer of simian virus 40 DNA is duplicated during virus growth in human cells and rhesus monkey kidney cells but not in green monkey kidney cells. Virology 310:173182.[PubMed]
15. Rinaldo CH, Traavik T, Hey A. 1998. The agnogene of the human polyomavirus BK is expressed. J Virol 72:62336236.[PubMed]
16. Zheng HY, Nishimoto Y, Chen Q, Hasegawa M, Zhong S, Ikegaya H, Ohno N, Sugimoto C, Takasaka T, Kitamura T, Yogo Y. 2007. Relationships between BK virus lineages and human populations. Microbes Infect 9:204213.[PubMed]
17. Nishimoto Y, Zheng HY, Zhong S, Ikegaya H, Chen Q, Sugimoto C, Kitamura T, Yogo Y. 2007. An Asian origin for subtype IV BK virus based on phylogenetic analysis. J Mol Evol 65:103111.[PubMed]
18. Pater A, Pater MM, di Mayorca G. 1980. Arrangement of the genome of the human papovavirus RF virus. J Virol 36:480487.[PubMed]
19. Pater MM, Pater A, di Mayorca G. 1981. Genome analysis of MG virus, a human papovavirus. J Virol 39:968972.[PubMed]
20. An P, Sáenz Robles MT, Pipas JM. 2012. Large T antigens of polyomaviruses: amazing molecular machines. Annu Rev Microbiol 66:213236.[PubMed]
21. Tevethia SS. 1990. Recognition of simian virus 40 T antigen by cytotoxic T lymphocytes. Mol Biol Med 7:8396.[PubMed]
22. Lowe DB, Shearer MH, Jumper CA, Bright RK, Kennedy RC. 2010. Tumor immunity against a simian virus 40 oncoprotein requires CD8+ T lymphocytes in the effector immune phase. J Virol 84:883893.[PubMed]
23. Gerits N, Moens U. 2012. Agnoprotein of mammalian polyomaviruses. Virology 432:316326.[PubMed]
24. Khalili K, Sariyer IK, Safak M. 2008. Small tumor antigen of polyomaviruses: role in viral life cycle and cell transformation. J Cell Physiol 215:309319.[PubMed]
25. Saribas AS, Coric P, Hamazaspyan A, Davis W, Axman R, White MK, Abou-Gharbia M, Childers W, Condra JH, Bouaziz S, Safak M. 2016. Emerging from the unknown: structural and functional features of agnoprotein of polyomaviruses. J Cell Physiol.[PubMed]
26. Schowalter RM, Buck CB. 2013. The Merkel cell polyomavirus minor capsid protein. PLoS Pathog 9:e1003558.[PubMed]
27. Raghava S, Giorda KM, Romano FB, Heuck AP, Hebert DN. 2013. SV40 late protein VP4 forms toroidal pores to disrupt membranes for viral release. Biochemistry 52:39393948.[PubMed]
28. Nicol JT, Robinot R, Carpentier A, Carandina G, Mazzoni E, Tognon M, Touzé A, Coursaget P. 2013. Age-specific seroprevalences of Merkel cell polyomavirus, human polyomaviruses 6, 7, and 9, and trichodysplasia spinulosa-associated polyomavirus. Clin Vaccine Immunol 20:363368.[PubMed]
29. Nicol JT, Liais E, Potier R, Mazzoni E, Tognon M, Coursaget P, Touzé A. 2014. Serological cross-reactivity between Merkel cell polyomavirus and two closely related chimpanzee polyomaviruses. PLoS One 9:e97030[CrossRef].[PubMed]
30. Kardas P, Leboeuf C,, and Hirsch HH. 2015. Optimizing JC and BK polyomavirus IgG testing for seroepidemiology and patient counseling. J Clin Virol. 71:2833.
31. Assetta B, Maginnis MS, Gracia Ahufinger I, Haley SA, Gee GV, Nelson CD, O'Hara BA, Allen Ramdial SA, Atwood WJ. 2013. 5-HT2 receptors facilitate JC polyomavirus entry. J Virol 87:1349013498.[PubMed]
32. Haley SA, O'Hara BA, Nelson CD, Brittingham FL, Henriksen KJ, Stopa EG, Atwood WJ. 2015. Human polyomavirus receptor distribution in brain parenchyma contrasts with receptor distribution in kidney and choroid plexus. Am J Pathol 185:22462258.[PubMed]
33. Elphick GF, Querbes W, Jordan JA, Gee GV, Eash S, Manley K, Dugan A, Stanifer M, Bhatnagar A, Kroeze WK, Roth BL, Atwood WJ. 2004. The human polyomavirus, JCV, uses serotonin receptors to infect cells. Science 306:13801383.[PubMed]
34. Ströh LJ, Maginnis MS, Blaum BS, Nelson CD, Neu U, Gee GV, O'Hara BA, Motamedi N, DiMaio D, Atwood WJ, Stehle T. 2015. The greater affinity of JC polyomavirus capsid for α2,6-linked lactoseries tetrasaccharide c than for other sialylated glycans Is a major determinant of Infectivity. J Virol 89:63646375.[PubMed]
35. Low JA, Magnuson B, Tsai B, Imperiale MJ. 2006. Identification of gangliosides GD1b and GT1b as receptors for BK virus. J Virol 80:13611366.[PubMed]
36. Erickson KD, Garcea RL, Tsai B. 2009. Ganglioside GT1b is a putative host cell receptor for the Merkel cell polyomavirus. J Virol 83:1027510279.[PubMed]
37. Schäfer G, Blumenthal MJ, Katz AA. 2015. Interaction of human tumor viruses with host cell surface receptors and cell entry. Viruses 7:25922617.[PubMed]
38. Ashok A, Atwood WJ. 2003. Contrasting roles of endosomal pH and the cytoskeleton in infection of human glial cells by JC virus and simian virus 40. J Virol 77:13471356.[PubMed]
39. Eash S, Querbes W, Atwood WJ. 2004. Infection of vero cells by BK virus is dependent on caveolae. J Virol 78:1158311590.[PubMed]
40. Bethge T, Hachemi HA, Manzetti J, Gosert R, Schaffner W, Hirsch HH. 2015. Sp1 sites in the noncoding control region of BK polyomavirus are key regulators of bidirectional viral early and late gene expression. J Virol 89:33963411.[PubMed]
41. Gosert R, Rinaldo CH, Funk GA, Egli A, Ramos E, Drachenberg CB, Hirsch HH. 2008. Polyomavirus BK with rearranged noncoding control region emerge in vivo in renal transplant patients and increase viral replication and cytopathology. J Exp Med 205:841852.[PubMed]
42. Priftakis P, Bogdanovic G, Kalantari M, Dalianis T. 2001. Overrepresentation of point mutations in the Sp1 site of the non-coding control region of BK virus in bone marrow transplanted patients with haemorrhagic cystitis. J Clin Virol 21:17.[PubMed]
43. Petrogiannis-Haliotis T, Sakoulas G, Kirby J, Koralnik IJ, Dvorak AM, Monahan-Earley R, De Girolami PC, De Girolami U, Upton M, Major EO, Pfister LA, Joseph JT. 2001. BK-related polyomavirus vasculopathy in a renal-transplant recipient. N Engl J Med 345:12501255.[PubMed]
44. Melnick JL, Stinebaugh S. 1962. Excretion of vacuolating SV-40 virus (papova virus group) after ingestion as a contaminant of oral poliovaccine. Proc Soc Exp Biol Med 109:965968.[PubMed]
45. Zaragoza C, Li RM, Fahle GA, Fischer SH, Raffeld M, Lewis AM Jr, Kopp JB. 2005. Squirrel monkeys support replication of BK virus more efficiently than simian virus 40: an animal model for human BK virus infection. J Virol 79:13201326.[PubMed]
46. Oster-Granite ML, Narayan O, Johnson RT, Herndon RM. 1978. Studies of cultured human and simian fetal brain cells. II. Infections with human (BK) and simian (SV40) papovaviruses. Neuropathol Appl Neurobiol 4:443455.[PubMed]
47. O'Neill FJ, Carney H, Hu Y. 1998. Host range analysis of simian virus 40, BK virus and chimaeric SV40/BKV: relative expression of large T-antigen and Vp1 in infected and transformed cells. Dev Biol Stand 94:191205.[PubMed]
48. O'Neill FJ, Xu XL, Miller TH. 1990. Host range determinant in the late region of SV40 and RF virus affecting growth in human cells. Intervirology 31:175187.[PubMed]
49. Lebkowski JS, Clancy S, Calos MP. 1985. Simian virus 40 replication in adenovirus-transformed human cells antagonizes gene expression. Nature 317:169171.[PubMed]
50. Lewis ED, Manley JL. 1985. Repression of simian virus 40 early transcription by viral DNA replication in human 293 cells. Nature 317:172175.[PubMed]
51. Low J, Humes HD, Szczypka M, Imperiale M. 2004. BKV and SV40 infection of human kidney tubular epithelial cells in vitro. Virology 323:182188.[PubMed]
52. Bernhoff E, Tylden GD, Kjerpeseth LJ, Gutteberg TJ, Hirsch HH, Rinaldo CH. 2010. Leflunomide inhibition of BK virus replication in renal tubular epithelial cells. J Virol 84:21502156.[PubMed]
53. Flaegstad T, Traavik T. 1987. BK virus in cell culture: infectivity quantitation and sequential expression of antigens detected by immunoperoxidase staining. J Virol Methods 16:139146.[PubMed]
54. Henriksen S, Tylden GD, Dumoulin A, Sharma BN, Hirsch HH, Rinaldo CH. 2014. The human fetal glial cell line SVG p12 contains infectious BK polyomavirus. J Virol 88:75567568.[PubMed]
55. O'Neill FJ, Greenlee JE, Dörries K, Clawson SA, Carney H. 2003. Propagation of archetype and nonarchetype JC virus variants in human fetal brain cultures: demonstration of interference activity by archetype JC virus. J Neurovirol 9:567576.[PubMed]
56. Broekema NM, Imperiale MJ. 2012. Efficient propagation of archetype BK and JC polyomaviruses. Virology 422:235241.[PubMed]
57. Schowalter RM, Reinhold WC, Buck CB. 2012. Entry tropism of BK and Merkel cell polyomaviruses in cell culture. PLoS One 7:e42181.[PubMed]
58. Pipas JM. 2009. SV40: cell transformation and tumorigenesis. Virology 384:294303.[PubMed]
59. Jha KK, Banga S, Palejwala V, Ozer HL. 1998. SV40-Mediated immortalization. Exp Cell Res 245:17.[PubMed]
60. O'Neill FJ, Frisque RJ, Xu X, Hu YX, Carney H. 1995. Immortalization of human cells by mutant and chimeric primate polyomavirus T-antigen genes. Oncogene 10:11311139.[PubMed]
61. Shuda M, Kwun HJ, Feng H, Chang Y, Moore PS. 2011. Human Merkel cell polyomavirus small T antigen is an oncoprotein targeting the 4E-BP1 translation regulator. J Clin Invest 121:36233634.[PubMed]
62. Bozic C, Richman S, Plavina T, Natarajan A, Scanlon JV, Subramanyam M, Sandrock A, Bloomgren G. 2011. Anti–John Cunnigham virus antibody prevalence in multiple sclerosis patients: baseline results of STRATIFY-1. Ann Neurol 70:742750.[PubMed]
63. Egli A, Infanti L, Dumoulin A, Buser A, Samaridis J, Stebler C, Gosert R, Hirsch HH. 2009. Prevalence of polyomavirus BK and JC infection and replication in 400 healthy blood donors. J Infect Dis 199:837846.[PubMed]
64. Kean JM, Rao S, Wang M, Garcea RL. 2009. Seroepidemiology of human polyomaviruses. PLoS Pathog 5:e1000363.[PubMed]
65. Reploeg MD, Storch GA, Clifford DB. 2001. BK virus: a clinical review. Clin Infect Dis 33:191202[CrossRef].[PubMed]
66. Viscidi RP, Rollison DE, Sondak VK, Silver B, Messina JL, Giuliano AR, Fulp W, Ajidahun A, Rivanera D. 2011. Age-specific seroprevalence of Merkel cell polyomavirus, BK virus, and JC virus. Clin Vaccine Immunol 18:17371743.[PubMed]
67. Gossai A, Waterboer T, Nelson HH, Michel A, Willhauck-Fleckenstein M, Farzan SF, Hoen AG, Christensen BC, Kelsey KT, Marsit CJ, Pawlita M, Karagas MR. 2016. Seroepidemiology of human polyomaviruses in a US population. Am J Epidemiol 183:6169.[PubMed]
68. White MK, Gordon J, Khalili K. 2013. The rapidly expanding family of human polyomaviruses: recent developments in understanding their life cycle and role in human pathology. PLoS Pathog 9:e1003206.[PubMed]
69. Kazem S, van der Meijden E, Feltkamp MC. 2013. The trichodysplasia spinulosa–associated polyomavirus: virological background and clinical implications. APMIS 121:770782.[PubMed]
70. Shah KV,. 1996. Polyomaviruses, p 20272043. In Fields BN, Knipe DM, Howley PM (ed), Fields Virology, 3rd ed. Raven Press, New York.
71. Butel JS, Lednicky JA. 1999. Cell and molecular biology of simian virus 40: implications for human infections and disease. J Natl Cancer Inst 91:119134.[PubMed]
72. Taronna A, Mazzoni E, Corallini A, Bononi I, Pietrobon S, Guerra G, Palmonari C, Borgna-Pignatti C, Comar M, Bovenzi M, Casali F, Marci R, Rezza G, Barbanti-Brodano G, Tognon M, Martini F. 2013. Serological evidence of an early seroconversion to simian virus 40 in healthy children and adolescents. PLoS One 8:e61182.[PubMed]
73. Thomas LD, Vilchez RA, White ZS, Zanwar P, Milstone AP, Butel JS, Dummer S. 2007. A prospective longitudinal study of polyomavirus shedding in lung-transplant recipients. J Infect Dis 195:442449.[PubMed]
74. Strizzi L, Vianale G, Giuliano M, Sacco R, Tassi F, Chiodera P, Casalini P, Procopio A. 2000. SV40, JC and BK expression in tissue, urine and blood samples from patients with malignant and nonmalignant pleural disease. Anticancer Res 20(2A):885889.[PubMed]
75. Carter JJ, Madeleine MM, Wipf GC, Garcea RL, Pipkin PA, Minor PD, Galloway DA. 2003. Lack of serologic evidence for prevalent simian virus 40 infection in humans. J Natl Cancer Inst 95:15221530.[PubMed]
76. Minor P, Pipkin P, Jarzebek Z, Knowles W. 2003. Studies of neutralising antibodies to SV40 in human sera. J Med Virol 70:490495.[PubMed]
77. Shah KV, Galloway DA, Knowles WA, Viscidi RP. 2004. Simian virus 40 (SV40) and human cancer: a review of the serological data. Rev Med Virol 14:231239.[PubMed]
78. Bofill-Mas S, Pina S, Girones R. 2000. Documenting the epidemiologic patterns of polyomaviruses in human populations by studying their presence in urban sewage. Appl Environ Microbiol 66:238245.[PubMed]
79. Shah KV, Daniel RW, Strickler HD, Goedert JJ. 1997. Investigation of human urine for genomic sequences of the primate polyomaviruses simian virus 40, BK virus, and JC virus. J Infect Dis 176:16181621.[PubMed]
80. Li RM, Mannon RB, Kleiner D, Tsokos M, Bynum M, Kirk AD, Kopp JB. 2002. BK virus and SV40 co-infection in polyomavirus nephropathy. Transplantation 74:14971504.[PubMed]
81. Baksh FK, Finkelstein SD, Swalsky PA, Stoner GL, Ryschkewitsch CF, Randhawa P. 2001. Molecular genotyping of BK and JC viruses in human polyomavirus–associated interstitial nephritis after renal transplantation. Am J Kidney Dis 38:354365.[PubMed]
82. Dubensky TW, Villarreal LP. 1984. The primary site of replication alters the eventual site of persistent infection by polyomavirus in mice. J Virol 50:541546.[PubMed]
83. Greenlee JE. 1979. Pathogenesis of K virus infection in newborn mice. Infect Immun 26:705713.[PubMed]
84. Bofill-Mas S, Formiga-Cruz M, Clemente-Casares P, Calafell F, Girones R. 2001. Potential transmission of human polyomaviruses through the gastrointestinal tract after exposure to virions or viral DNA. J Virol 75:1029010299.[PubMed]
85. Ricciardiello L, Laghi L, Ramamirtham P, Chang CL, Chang DK, Randolph AE, Boland CR. 2000. JC virus DNA sequences are frequently present in the human upper and lower gastrointestinal tract. Gastroenterology 119:12281235.[PubMed]
86. Vanchiere JA, Nicome RK, Greer JM, Demmler GJ, Butel JS. 2005. Frequent detection of polyomaviruses in stool samples from hospitalized children. J Infect Dis 192:658664.[PubMed]
87. Sundsfjord A, Spein AR, Lucht E, Flaegstad T, Seternes OM, Traavik T. 1994. Detection of BK virus DNA in nasopharyngeal aspirates from children with respiratory infections but not in saliva from immunodeficient and immunocompetent adult patients. J Clin Microbiol 32:13901394.[PubMed]
88. Jeffers LK, Madden V, Webster-Cyriaque J. 2009. BK virus has tropism for human salivary gland cells in vitro: implications for transmission. Virology 394:183193.[PubMed]
89. Feltkamp MC, Kazem S, van der Meijden E, Lauber C, Gorbalenya AE. 2013. From Stockholm to Malawi: recent developments in studying human polyomaviruses. J Gen Virol 94:482496.[PubMed]
90. DeCaprio JA, Garcea RL. 2013. A cornucopia of human polyomaviruses. Nat Rev Microbiol 11:264276.[PubMed]
91. Samimi M, Gardair C, Nicol JT, Arnold F, Touzé A, Coursaget P. 2015. Merkel cell polyomavirus in Merkel cell carcinoma: clinical and therapeutic perspectives. Semin Oncol 42:347358.[PubMed]
92. Kazem S, van der Meijden E, Kooijman S, Rosenberg AS, Hughey LC, Browning JC, Sadler G, Busam K, Pope E, Benoit T, Fleckman P, de Vries E, Eekhof JA, Feltkamp MC. 2012. Trichodysplasia spinulosa is characterized by active polyomavirus infection. J Clin Virol 53:225230.[PubMed]
93. Berger JR, Kaszovitz B, Post MJ, Dickinson G. 1987. Progressive multifocal leukoencephalopathy associated with human immunodeficiency virus infection. A review of the literature with a report of sixteen cases. Ann Intern Med 107:7887.[PubMed]
94. Khanna N, Elzi L, Mueller NJ, Garzoni C, Cavassini M, Fux CA, Vernazza P, Bernasconi E, Battegay M, Hirsch HH Swiss HIV Cohort Study. 2009. Incidence and outcome of progressive multifocal leukoencephalopathy over 20 years of the Swiss HIV Cohort Study. Clin Infect Dis 48:14591466.[PubMed]
95. Casado JL, Corral I, García J, Martinez-San Millán J, Navas E, Moreno A, Moreno S. 2014. Continued declining incidence and improved survival of progressive multifocal leukoencephalopathy in HIV/AIDS patients in the current era. Eur J Clin Microbiol Infect Dis 33:179187.[PubMed]
96. Toussirot É, Bereau M. 2014. The risk of progressive multifocal leukoencephalopathy under biological agents used in the treatment of chronic inflammatory diseases. Inflamm Allergy Drug Targets 13:121127.[PubMed]
97. Mateen FJ, Muralidharan R, Carone M, van de Beek D, Harrison DM, Aksamit AJ, Gould MS, Clifford DB, Nath A. 2011. Progressive multifocal leukoencephalopathy in transplant recipients. Ann Neurol 70:305322.[PubMed]
98. Hirsch HH, Kardas P, Kranz D, Leboeuf C. 2013. The human JC polyomavirus (JCPyV): virological background and clinical implications. APMIS 121:685727[CrossRef].[PubMed]
99. Polman CH, O'Connor PW, Havrdova E, Hutchinson M, Kappos L, Miller DH, Phillips JT, Lublin FD, Giovannoni G, Wajgt A, Toal M, Lynn F, Panzara MA, Sandrock AW AFFIRM Investigators. 2006. A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis. N Engl J Med 354:899910.[PubMed]
100. Carson KR, Evens AM, Richey EA, Habermann TM, Focosi D, Seymour JF, Laubach J, Bawn SD, Gordon LI, Winter JN, Furman RR, Vose JM, Zelenetz AD, Mamtani R, Raisch DW, Dorshimer GW, Rosen ST, Muro K, Gottardi-Littell NR, Talley RL, Sartor O, Green D, Major EO, Bennett CL. 2009. Progressive multifocal leukoencephalopathy after rituximab therapy in HIV-negative patients: a report of 57 cases from the Research on Adverse Drug Events and Reports project. Blood 113:48344840.[PubMed]
101. Faulkner M. 2015. Risk of progressive multifocal leukoencephalopathy in patients with multiple sclerosis. Expert Opin Drug Saf 14:17371748.[PubMed]
102. Plavina T, Subramanyam M, Bloomgren G, Richman S, Pace A, Lee S, Schlain B, Campagnolo D, Belachew S, Ticho B. 2014. Anti-JC virus antibody levels in serum or plasma further define risk of natalizumab-associated progressive multifocal leukoencephalopathy. Ann Neurol 76:802812.[PubMed]
103. Warnke C, von Geldern G, Markwerth P, Dehmel T, Hoepner R, Gold R, Pawlita M, Kümpfel T, Mäurer M, Stangel M, Wegner F, Hohlfeld R, Straeten V, Limmroth V, Weber T, Hermsen D, Kleinschnitz C, Hartung HP, Wattjes MP, Svenningson A, Major E, Olsson T, Kieseier BC, Adams O. 2014. Cerebrospinal fluid JC virus antibody index for diagnosis of natalizumab-associated progressive multifocal leukoencephalopathy. Ann Neurol 76:792801.[PubMed]
104. Kuhle J, Gosert R, Bühler R, Derfuss T, Sutter R, Yaldizli O, Radue EW, Ryschkewitsch C, Major EO, Kappos L, Frank S, Hirsch HH. 2011. Management and outcome of CSF-JC virus PCR-negative PML in a natalizumab-treated patient with MS. Neurology 77:20102016.[PubMed]
105. Binet I, Nickeleit V, Hirsch HH, Prince O, Dalquen P, Gudat F, Mihatsch MJ, Thiel G. 1999. Polyomavirus disease under new immunosuppressive drugs: a cause of renal graft dysfunction and graft loss. Transplantation 67:918922.[PubMed]
106. Randhawa PS, Finkelstein S, Scantlebury V, Shapiro R, Vivas C, Jordan M, Picken MM, Demetris AJ. 1999. Human polyoma virus–associated interstitial nephritis in the allograft kidney. Transplantation 67:103109.[PubMed]
107. Nickeleit V, Klimkait T, Binet IF, Dalquen P, Del Zenero V, Thiel G, Mihatsch MJ, Hirsch HH. 2000. Testing for polyomavirus type BK DNA in plasma to identify renal-allograft recipients with viral nephropathy. N Engl J Med 342:13091315.[PubMed]
108. Hirsch HH, Knowles W, Dickenmann M, Passweg J, Klimkait T, Mihatsch MJ, Steiger J. 2002. Prospective study of polyomavirus type BK replication and nephropathy in renal-transplant recipients. N Engl J Med 347:488496.[PubMed]
109. Apperley JF, Rice SJ, Bishop JA, Chia YC, Krausz T, Gardner SD, Goldman JM. 1987. Late-onset hemorrhagic cystitis associated with urinary excretion of polyomaviruses after bone marrow transplantation. Transplantation 43:108112.[PubMed]
110. Bedi A, Miller CB, Hanson JL, Goodman S, Ambinder RF, Charache P, Arthur RR, Jones RJ. 1995. Association of BK virus with failure of prophylaxis against hemorrhagic cystitis following bone marrow transplantation. J Clin Oncol 13:11031109.[PubMed]
111. Giraud G, Priftakis P, Bogdanovic G, Remberger M, Dubrulle M, Hau A, Gutmark R, Mattson J, Svahn BM, Ringden O, Winiarski J, Ljungman P, Dalianis T. 2008. BK-viruria and haemorrhagic cystitis are more frequent in allogeneic haematopoietic stem cell transplant patients receiving full conditioning and unrelated-HLA-mismatched grafts. Bone Marrow Transplant 41:737742.[PubMed]
112. Koskenvuo M, Dumoulin A, Lautenschlager I, Auvinen E, Mannonen L, Anttila VJ, Jahnukainen K, Saarinen-Pihkala UM, Hirsch HH. 2013. BK polyomavirus–associated hemorrhagic cystitis among pediatric allogeneic bone marrow transplant recipients: treatment response and evidence for nosocomial transmission. J Clin Virol 56:7781.[PubMed]
113. Cesaro S, Dalianis T, Rinaldo CH, Koseknuovo M, Einsele H,, and Hirsch HH, 2016. ECIL 6—Guidelines for the prevention, diagnosis, and treatment of BK polyomavirus disease in stem cell transplant patients.
114. Rosen S, Harmon W, Krensky AM, Edelson PJ, Padgett BL, Grinnell BW, Rubino MJ, Walker DL. 1983. Tubulo-interstitial nephritis associated with polyomavirus (BK type) infection. N Engl J Med 308:11921196.[PubMed]
115. de Silva LM, Bale P, de Courcy J, Brown D, Knowles W. 1995. Renal failure due to BK virus infection in an immunodeficient child. J Med Virol 45:192196.[PubMed]
116. Crum-Cianflone N, Quigley M, Utz G, Hale B. 2007. BK virus–associated renal failure among HIV patients. AIDS 21:15011502.[PubMed]
117. Kenan DJ, Mieczkowski PA, Burger-Calderon R, Singh HK, Nickeleit V. 2015. The oncogenic potential of BK-polyomavirus is linked to viral integration into the human genome. J Pathol 237:379389.[PubMed]
118. Papadimitriou JC, Randhawa P, Rinaldo CH, Drachenberg CB, Alexiev B, Hirsch HH. 2016. BK polyomavirus infection and renourinary tumorigenesis. Am J Transplant 16:398406.[PubMed]
119. Coursaget P, Samimi M, Nicol JT, Gardair C, Touzé A. 2013. Human Merkel cell polyomavirus: virological background and clinical implications. APMIS 121:755769.[PubMed]
120. Prieto Muñoz I, Pardo Masferrer J, Olivera Vegas J, Medina Montalvo MS, Jover Díaz R, Pérez Casas AM. 2013. Merkel cell carcinoma from 2008 to 2012: reaching a new level of understanding. Cancer Treat Rev 39:421429.[PubMed]
121. Feng H, Shuda M, Chang Y, Moore PS. 2008. Clonal integration of a polyomavirus in human Merkel cell carcinoma. Science 319:10961100.[PubMed]
122. Wieland U, Silling S, Hellmich M, Potthoff A, Pfister H, Kreuter A. 2014. Human polyomaviruses 6, 7, 9, 10 and Trichodysplasia spinulosa–associated polyomavirus in HIV-infected men. J Gen Virol 95:928932.[PubMed]
123. Axthelm MK, Koralnik IJ, Dang X, Wüthrich C, Rohne D, Stillman IE, Letvin NL. 2004. Meningoencephalitis and demyelination are pathologic manifestations of primary polyomavirus infection in immunosuppressed rhesus monkeys. J Neuropathol Exp Neurol 63:750758.[PubMed]
124. Simon MA, Ilyinskii PO, Baskin GB, Knight HY, Pauley DR, Lackner AA. 1999. Association of simian virus 40 with a central nervous system lesion distinct from progressive multifocal leukoencephalopathy in macaques with AIDS. Am J Pathol 154:437446.[PubMed]
125. Nakamichi K, Takayama-Ito M, Nukuzuma S, Kurane I, Saijo M. 2010. Long-term infection of adult mice with murine polyomavirus following stereotaxic inoculation into the brain. Microbiol Immunol 54:475482.[PubMed]
126. Greenlee JE, Clawson SH, Phelps RC, Stroop WG. 1994. Distribution of K-papovavirus in infected newborn mice. J Comp Pathol 111:259268.[PubMed]
127. Greenlee JE. 1981. Effect of host age on experimental K virus infection in mice. Infect Immun 33:297303.[PubMed]
128. Greenlee JE, Phelps RC, Stroop WG. 1991. The major site of murine K papovavirus persistence and reactivation is the renal tubular epithelium. Microb Pathog 11:237247.[PubMed]
129. White MK, Gordon J, Berger JR, Khalili K. 2015. Animal models for progressive multifocal leukoencephalopathy. J Cell Physiol 230:28692874.[PubMed]
130. Kondo Y, Windrem MS, Zou L, Chandler-Militello D, Schanz SJ, Auvergne RM, Betstadt SJ, Harrington AR, Johnson M, Kazarov A, Gorelik L, Goldman SA. 2014. Human glial chimeric mice reveal astrocytic dependence of JC virus infection. J Clin Invest 124:53235336.[PubMed]
131. Simon-Santamaria J, Rinaldo CH, Kardas P, Li R, Malovic I, Elvevold K, McCourt P, Smedsrød B, Hirsch HH, Sørensen KK. 2014. Efficient uptake of blood-borne BK and JC polyomavirus-like particles in endothelial cells of liver sinusoids and renal vasa recta. PLoS One 9:e111762.[PubMed]
132. Grundhoff A, Fischer N. 2015. Merkel cell polyomavirus, a highly prevalent virus with tumorigenic potential. Curr Opin Virol 14:129137.[PubMed]
133. Caldarelli-Stefano R, Vago L, Omodeo-Zorini E, Mediati M, Losciale L, Nebuloni M, Costanzi G, Ferrante P. 1999. Detection and typing of JC virus in autopsy brains and extraneural organs of AIDS patients and non-immunocompromised individuals. J Neurovirol 5:125133.[PubMed]
134. Greenlee JE, Clawson SA, Carney HC, O'Neill FJ. 2005. Detection of JC virus early region DNA sequences in brains of individuals without progressive multifocal leukoencephalopathy or immunodeficiency. Ann. Neurol. Suppl 9:
135. Pietropaolo V, Fioriti D, Simeone P, Videtta M, Di Taranto C, Arancio A, Orsi N, Degener AM. 2003. Detection and sequence analysis of human polyomaviruses DNA from autoptic samples of HIV-1 positive and negative subjects. Int J Immunopathol Pharmacol 16:269276.[PubMed]
136. Tan CS, Ellis LC, Wüthrich C, Ngo L, Broge TA Jr, Saint-Aubyn J, Miller JS, Koralnik IJ. 2010. JC virus latency in the brain and extraneural organs of patients with and without progressive multifocal leukoencephalopathy. J Virol 84:92009209.[PubMed]
137. White FAI III, Ishaq M, Stoner GL, Frisque RJ. 1992. JC virus DNA is present in many human brain samples from patients without progressive multifocal leukoencephalopathy. J Virol 66:57265734.[PubMed]
138. Perez-Liz G, Del Valle L, Gentilella A, Croul S, Khalili K. 2008. Detection of JC virus DNA fragments but not proteins in normal brain tissue. Ann Neurol 64:379387.[PubMed]
139. Wollebo HS, White MK, Gordon J, Berger JR, Khalili K. 2015. Persistence and pathogenesis of the neurotropic polyomavirus JC. Ann Neurol 77:560570.[PubMed]
140. Houff SA, Major EO, Katz DA, Kufta CV, Sever JL, Pittaluga S, Roberts JR, Gitt J, Saini N, Lux W. 1988. Involvement of JC virus–infected mononuclear cells from the bone marrow and spleen in the pathogenesis of progressive multifocal leukoencephalopathy. N Engl J Med 318:301305.[PubMed]
141. Chapagain ML, Nerurkar VR. 2010. Human polyomavirus JC (JCV) infection of human B lymphocytes: a possible mechanism for JCV transmigration across the blood-brain barrier. J Infect Dis 202:184191.[PubMed]
142. Dörries K, Vogel E, Günther S, Czub S. 1994. Infection of human polyomaviruses JC and BK in peripheral blood leukocytes from immunocompetent individuals. Virology 198:5970.[PubMed]
143. Dubois V, Moret H, Lafon ME, Janvresse CB, Dussaix E, Icart J, Karaterki A, Ruffault A, Taoufik Y, Vignoli C, Ingrand D. 1998. Prevalence of JC virus viraemia in HIV-infected patients with or without neurological disorders: a prospective study. J Neurovirol 4:539544.[PubMed]
144. Dolei A, Pietropaolo V, Gomes E, Di Taranto C, Ziccheddu M, Spanu MA, Lavorino C, Manca M, Degener AM. 2000. Polyomavirus persistence in lymphocytes: prevalence in lymphocytes from blood donors and healthy personnel of a blood transfusion centre. J Gen Virol 81:19671973.[PubMed]
145. Lafon ME, Dutronc H, Dubois V, Pellegrin I, Barbeau P, Ragnaud JM, Pellegrin JL, Fleury HJ. 1998. JC virus remains latent in peripheral blood B lymphocytes but replicates actively in urine from AIDS patients. J Infect Dis 177:15021505.[PubMed]
146. Koralnik IJ, Schmitz JE, Lifton MA, Forman MA, Letvin NL. 1999. Detection of JC virus DNA in peripheral blood cell subpopulations of HIV-1-infected individuals. J Neurovirol 5:430435.[PubMed]
147. Vallbracht A, Löhler J, Gossmann J, Glück T, Petersen D, Gerth H-J, Gencic M, Dörries K. 1993. Disseminated BK type polyomavirus infection in an AIDS patient associated with central nervous system disease. Am J Pathol 143:2939.[PubMed]